Enanta Pharmaceuticals Inc.

ENTA | NASDAQ

Price Alert Chart Builder DCF Calculator

$12.29

+$0.18 (+1.49%)

Sep 22, 2026, 12:51 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Sep 29, 2025	FY 2024 Sep 29, 2024	FY 2023 Sep 29, 2023	FY 2022 Sep 29, 2022	FY 2021 Sep 29, 2021	FY 2020 Sep 29, 2020
Net Income	-81.89M	-116.05M	-133.82M	-121.76M	-79M	-36.17M
Depreciation & Amortization	5.09M	2.34M	2.37M	2.97M	3.33M	3.64M
Stock-Based Compensation	18.57M	26.8M	28.22M	26.97M	20.99M	19.58M
Other Working Capital	9.46M	6.57M	-243K	-372K	6.84M	-14.04M
Other Non-Cash Items	-946K	1.02M	-7.95M	242K	-1.98M	-3.47M
Deferred Income Tax	n/a	n/a	n/a	n/a	345K	10.61M
Change in Working Capital	39.91M	7.13M	8.02M	6.79M	-13.69M	12.9M
Operating Cash Flow	-19.27M	-78.76M	-103.15M	-84.78M	-70M	7.09M
Capital Expenditures	-12.9M	-17.95M	-9.06M	-2.13M	-750K	-1.45M
Cash Acquisitions	n/a	n/a	44.52M	-54.9M	-37.74M	n/a
Purchase of Investments	-209.63M	-307.28M	-373.39M	-171.45M	-307.35M	-338.55M
Sales Maturities Of Investments	262.87M	383.47M	328.87M	228.47M	345.09M	359.83M
Other Investing Acitivies	n/a	n/a	-44.52M	54.9M	37.74M	n/a
Investing Cash Flow	40.35M	58.24M	-53.58M	54.9M	36.99M	19.83M
Debt Repayment	-26.49M	-27.48M	199.68M	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-277K	-294K	-3.76M	-1.23M	-534K	8.98M
Financial Cash Flow	-26.62M	-27.63M	198.13M	20.03M	3.08M	8.98M
Net Cash Flow	-5.54M	-48.16M	41.39M	-9.85M	-29.93M	35.9M
Free Cash Flow	-32.17M	-96.71M	-112.21M	-86.91M	-70.75M	5.64M
Adj. Free Cash Flow	-50.73M	-123.51M	-140.43M	-113.88M	-91.74M	-13.93M
Maintenance CapEx	-12.9M	-17.95M	-9.06M	-2.13M	-750K	-1.45M
Growth CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-32.17M	-96.71M	-112.21M	-86.91M	-70.75M	5.64M